Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of the LC-NA System in Experimental Sleep Fragmentation With Buccal Dexmedetomidine
NCT07167316Phase 1Recruiting
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in sleep fragmentation (6 arms). Primary endpoints: Total Sleep Time, Wake After Sleep Onset and 8 more. Started May 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep fragmentation
Beyond the preview
Go deeper on NCT07167316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07167316.